RxSight, Inc. (NASDAQ: RXST) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Aliso Viejo, California, the company focuses on the development and..
Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing the attention of investors with its promising pipeline of cancer therapies and a compelling potential upside of 47.21%, as suggested by analyst target..
AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with an impressive potential upside of 38.22%, as suggested by its average target price. As a clinical-stage biotechnology company, AnaptysBio is at..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling opportunity in the healthcare sector, particularly within the dynamic biotechnology industry. With a market capitalization of $1.08 billion, Maravai’s presence in..
For investors eyeing opportunities in the healthcare sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents a compelling case with a significant 210.50% potential upside, according to recent analyst ratings. As a..
REGENXBIO Inc. (NASDAQ: RGNX) is a name making waves in the biotechnology sector with its innovative approach to tackling genetic disorders through gene therapy. As a clinical-stage biotech firm, REGENXBIO..
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector as a clinical-stage precision medicines company focusing on advancing small molecule therapeutic discovery in targeted oncology and genetic disease..
Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, is drawing significant attention from investors with its potential upside of 263.94%. As a company specialized in the delivery..
Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in prophylactic vaccines, is capturing the attention of investors due to its significant potential upside of 119.26%, as indicated by analyst..
For investors eyeing the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. This clinical-stage biopharmaceutical firm, headquartered in Brisbane, California, is pioneering advancements in cancer and inflammatory..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a prominent player in the biotechnology sector, is currently turning heads with its impressive potential upside of 162.17%, according to recent analyst ratings. With a..
InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly within the medical care facilities industry, has been making headlines with its innovative approach to senior care...
Xencor, Inc. (XNCR), a prominent player in the biotechnology industry, stands out with its promising potential upside of 121.83%, making it a stock worth considering for individual investors seeking exposure..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, is drawing attention from investors with its strategic position in the burgeoning Software-as-a-Service (SaaS) sector tailored for..
CareDx, Inc. (CDNA) is a key player in the healthcare sector, specializing in diagnostics and research aimed at improving outcomes for transplant patients. Headquartered in Brisbane, California, CareDx provides a..
Immunome, Inc. (NASDAQ: IMNM) is capturing investor attention with its impressive potential upside of 62.72%, according to recent analyst ratings. With a focus on developing innovative treatments for cancer through..
Investors with a keen eye on the biotechnology sector might find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) a compelling addition to their portfolios. With a market cap of $1.41 billion, this..
Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning player in the biotechnology sector, is drawing significant attention from investors, driven largely by its impressive 21.29% potential upside based on current analyst..
Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor attention with its innovative approach to cancer treatment and a compelling potential upside of over 121%. Specializing in medical devices within the..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a biotechnology firm focused on developing treatments for chronic cough conditions, presents a compelling investment opportunity with an impressive potential upside of 80.45%. Situated within..
